Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 240

The DOI matches its Crossref record.

Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary Stents: Igaki-Tamai Stents

Nishio, Soji, Kosuga, Kunihiko, Igaki, Keiji, Okada, Masaharu, Kyo, Eisho, Tsuji, Takafumi, Takeuchi, Eiji, Inuzuka, Yasutaka, Takeda, Shinsaku, Hata, Tatsuhiko, Takeuchi, Yuzo, Kawada, Yoshitaka, Harita, Takeshi, Seki, Junya, Akamatsu, Shunji, Hasegawa, Shinichi, Bruining, Nico, Brugaletta, Salvatore, de Winter, Sebastiaan, Muramatsu, Takashi, Onuma, Yoshinobu, Serruys, Patrick W., Ikeguchi, Shigeru·2012·Circulation

Abstract

Background—: The purpose of this study was to evaluate the long-term safety of the Igaki-Tamai stent, the first-in-human fully biodegradable coronary stent made of poly- l -lactic acid. Methods and Results—: Between September 1998 and April 2000, 50 patients with 63 lesions were treated electively with 84 Igaki-Tamai stents. Overall clinical follow-up (>10 years) of major adverse cardiac events and rates of scaffold thrombosis was analyzed together with the results of angiography and intravascular ultrasound. Major adverse cardiac events included all-cause death, nonfatal myocardial infarction, and target lesion revascularization/target vessel revascularization. During the overall clinical follow-up period (121±17 months), 2 patients were lost to follow-up. There were 1 cardiac death, 6 noncardiac deaths, and 4 myocardial infarctions. Survival rates free of all-cause death, cardiac death, and major adverse cardiac events at 10 years were 87%, 98%, and 50%, respectively. The cumulative rates of target lesion revascularization (target vessel revascularization) were 16% (16%) at 1 year, 18% (22%) at 5 years, and 28% (38%) at 10 years. Two definite scaffold thromboses (1 subacute, 1 very late) were recorded. The latter case was related to a sirolimus-eluting stent, which was implanted for a lesion proximal to an Igaki-Tamai stent. From the analysis of intravascular ultrasound data, the stent struts mostly disappeared within 3 years. The external elastic membrane area and stent area did not change. Conclusion—: Acceptable major adverse cardiac events and scaffold thrombosis rates without stent recoil and vessel remodeling suggested the long-term safety of the Igaki-Tamai stent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.110.000901

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 240

Metadata

Authors
Nishio, S., Kosuga, K., Igaki, K., Okada, M., Kyo, E., Tsuji, T., Takeuchi, E., Inuzuka, Y., Takeda, S., Hata, T., Takeuchi, Y., Kawada, Y., Harita, T., Seki, J., Akamatsu, S., Hasegawa, S., Bruining, N., Brugaletta, S., de Winter, S., Muramatsu, T., Onuma, Y., Serruys, P. W., & Ikeguchi, S.
Venue
Circulation
Published
2012-05-15
Volume
125
Issue
19
Pages
2343-2353
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2886483702
Cited by
240
References
0
FWCI
31.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary Stents: Igaki-Tamai Stents. https://app.cochat.ai/papers/10.1161/circulationaha.110.000901
The paper
Nishio, S., Kosuga, K., Igaki, K., Okada, M., Kyo, E., Tsuji, T., Takeuchi, E., Inuzuka, Y., Takeda, S., Hata, T., Takeuchi, Y., Kawada, Y., Harita, T., Seki, J., Akamatsu, S., Hasegawa, S., Bruining, N., Brugaletta, S., de Winter, S., . . . Ikeguchi, S. (2012). Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary Stents: Igaki-Tamai Stents. Circulation. https://doi.org/10.1161/circulationaha.110.000901

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.